2019

The case of green tea extract discussed at ESMO 2019

With nutriceuticals regularly making headlines for their alleged benefits in the treatment or prevention of cancer, some clinicians are endeavouring to scientifically investigate claims and dispel fake news that can give false hope to patients….

Read More



Are we reaching a turning point in metastatic prostate cancer?

At yesterday’s Presidential Symposium, a Late-Breaking Abstract presentation of the PROfound study reported a clinically meaningful benefit in radiological progression-free survival (PFS) with olaparib in men with BRCA1, BRCA2 or ATM mutations in metastatic castration-resistant…

Read More